```html

Acute Nephritis – A Complete Patient Guide

Overview

Acute nephritis (also called acute interstitial nephritis or acute inflammatory kidney disease) is a sudden inflammation of the kidney’s tubules, interstitium, and sometimes glomeruli. The inflammation interferes with the kidneys’ ability to filter waste, balance fluids, and regulate electrolytes.

• Who it affects: Adults of any age, but it is most common in people aged 30‑70. Certain sub‑types, such as post‑streptococcal acute glomerulonephritis, are more frequent in children.
• Prevalence: In the United States, acute interstitial nephritis accounts for roughly 1‑2 % of all kidney biopsies, translating to an estimated 200,000–300,000 new cases worldwide each year<sup>[1]</sup>. Post‑infectious acute glomerulonephritis affects about 1‑2 per 100,000 children annually in developed nations<sup>[2]</sup>.

Symptoms

Symptoms can appear within hours to several weeks after the inciting event (infection, drug exposure, etc.). The pattern varies by cause, but the following list covers the most frequently reported manifestations:

General symptoms

• Fever – often low‑grade, but may be high if infection is the trigger.
• Fatigue & malaise – due to reduced kidney function and systemic inflammation.
• Muscle aches (myalgia) or joint pain.

Urinary symptoms

• Hematuria – pink, red, or brown urine; can be microscopic or visible to the naked eye.
• Proteinuria – foamy or frothy urine, often detected by dip‑stick testing.
• Polyuria or oliguria – either increased urine output (due to loss of concentrating ability) or decreased output (<500 mL/24 h).
• Foamy or “bubbly” urine – a sign of protein leakage.
• Painful urination – rare, but may occur if there is concurrent urinary tract infection.

Fluid‑balance symptoms

• Edema – swelling of the ankles, feet, or face, reflecting sodium and water retention.
• Shortness of breath – from fluid accumulation in the lungs (pulmonary edema).
• Weight gain – rapid gain over days suggests fluid overload.

Electrolyte‑related symptoms

• Muscle cramps or weakness – often due to low potassium (hypokalemia) or low calcium.
• Cardiac palpitations – may indicate abnormal potassium or magnesium levels.

Other possible findings

• Rash – especially with drug‑induced interstitial nephritis (e.g., antibiotic or NSAID reaction).
• Joint swelling – can accompany systemic drug hypersensitivity.

Causes and Risk Factors

Acute nephritis is not a single disease; it encompasses several etiologies that share the final pathway of kidney inflammation.

Infectious causes

• Post‑streptococcal glomerulonephritis – follows a throat or skin infection with Group A Streptococcus, usually 1‑3 weeks later.
• Viral infections – hepatitis B & C, HIV, and recently SARS‑CoV‑2 have been linked to acute glomerulonephritis.
• Bacterial infections – staphylococcal infection, endocarditis, or bacterial sepsis can trigger a hypersensitivity reaction in the kidney.

Drug‑induced (most common cause of acute interstitial nephritis)

• Antibiotics – especially β‑lactams (penicillins, cephalosporins) and sulfonamides.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs).
• Proton‑pump inhibitors (omeprazole, pantoprazole).
• Diuretics, anti‑epileptics (phenytoin), allopurinol, and some immunotherapy agents.

Systemic diseases

• Systemic lupus erythematosus (lupus nephritis).
• Sjögren’s syndrome, sarcoidosis, and vasculitides (e.g., ANCA‑associated vasculitis).

Other triggers

• Contrast agents used in imaging studies.
• Heavy metals (lead, mercury) and certain toxins.

Risk factors

• Recent use of implicated medications (especially within 1‑4 weeks).
• History of allergic reactions or drug hypersensitivity.
• Pre‑existing chronic kidney disease (CKD) – lower renal reserve makes injury more apparent.
• Age > 60 years – reduced drug clearance.
• Autoimmune disease background.

Diagnosis

Because symptoms overlap with many other renal and systemic conditions, a systematic approach is essential.

Clinical assessment

• Detailed medical history – recent infections, medication changes, allergies, and systemic disease.
• Physical exam – check for edema, blood pressure, rash, and any signs of fluid overload.

Laboratory tests

• Serum creatinine & eGFR – sudden rise indicates reduced filtration.
• Blood urea nitrogen (BUN) – usually elevated, BUN/creatinine ratio helps differentiate prerenal from intrinsic causes.
• Urinalysis – key findings: hematuria, proteinuria, white blood cell casts, eosinophils (suggestive of drug‑induced interstitial nephritis).
• Complete blood count (CBC) – may reveal eosinophilia in drug reactions.
* Complement levels (C3, C4) – low C3 is typical of post‑streptococcal glomerulonephritis. * Antistreptolysin O (ASO) titer – elevated after recent streptococcal infection. * Serologic tests for autoimmune disease – ANA, anti‑dsDNA, ANCA, anti‑GBM as indicated.

Imaging

• Renal ultrasound – evaluates size, obstruction, and parenchymal echogenicity; usually normal in acute interstitial nephritis.
• CT or MRI – reserved for complicated cases or when an obstructive process is suspected.

Kidney biopsy

Considered the gold standard when the diagnosis remains uncertain after non‑invasive work‑up, especially to differentiate interstitial nephritis from glomerulonephritis or to assess disease severity. The biopsy typically shows interstitial inflammatory infiltrates (lymphocytes, eosinophils) and tubular injury.

Diagnostic criteria (drug‑induced interstitial nephritis)

1. Recent exposure to a known offending drug.
2. Acute rise in serum creatinine.
3. Urinalysis showing sterile pyuria, white‑blood‑cell casts, and eosinophiluria.
4. Improvement after drug withdrawal (supportive evidence).

Treatment Options

Management is tailored to the underlying cause, severity of kidney dysfunction, and patient comorbidities.

Immediate steps

• Discontinue the offending agent – the most crucial intervention for drug‑induced cases.
• Hydration with isotonic saline (unless volume‑overloaded) to maintain renal perfusion.

Pharmacologic therapy

1. Corticosteroids

Oral prednisone (0.5‑1 mg/kg/day) or IV methylprednisolone is commonly used for moderate‑to‑severe interstitial nephritis or when renal function does not improve after drug withdrawal. A typical taper lasts 4‑6 weeks.<sup>[3]</sup>

2. Antimicrobial treatment

• For post‑streptococcal glomerulonephritis – antibiotics (penicillin or amoxicillin) to eradicate residual streptococci, though they do not change the renal course.
• In cases of bacterial sepsis or endocarditis – targeted antibiotics based on cultures.

3. Immunosuppressive agents

Reserved for autoimmune‑related acute nephritis (e.g., lupus, ANCA‑vasculitis). Options include cyclophosphamide, mycophenolate mofetil, or rituximab, guided by a nephrologist.

4. Blood pressure control

ACE inhibitors or ARBs are used if proteinuria is significant; they also protect remaining nephron function.

Supportive measures

• Fluid management – avoid both dehydration and volume overload; diuretics (e.g., furosemide) may be needed for edema.
• Electrolyte correction – replace potassium, magnesium, or calcium as needed.
• Dialysis – temporary hemodialysis or peritoneal dialysis when creatinine > 8 mg/dL, refractory hyperkalemia, severe acidosis, or pulmonary edema.

Lifestyle & dietary recommendations during treatment

• Low‑sodium diet (<2 g/day) to reduce fluid retention.
• Moderate protein intake (0.8‑1.0 g/kg/day) to limit nitrogen waste.
• Avoid NSAIDs, herbal supplements, and other nephrotoxic substances.
• Stay well‑hydrated (unless instructed otherwise).

Living with Acute Nephritis

Even though “acute” implies a relatively short‑term illness, the period of recovery can last weeks to months, and some patients develop chronic kidney changes. The following tips help maintain health and prevent relapse.

Monitoring

• Check serum creatinine and electrolytes at least weekly during the first month, then every 2‑4 weeks until stable.
• Track urine output and look for new swelling, dark urine, or foamy urine.
• Blood pressure home monitoring – aim for <130/80 mmHg unless otherwise directed.

Medication safety

• Keep an up‑to‑date medication list and share it with every provider.
• Ask pharmacists to flag nephrotoxic drugs.
• Never restart a previously offending medication without specialist approval.

Dietary habits

• Follow the renal‑friendly diet discussed above.
• Limit high‑potassium foods (bananas, oranges, potatoes) if labs show hyperkalemia.
• Stay within recommended fluid limits if you develop fluid overload.

Physical activity

Light‑to‑moderate aerobic exercise (walking, swimming) is encouraged once energy levels improve, but avoid heavy lifting that spikes blood pressure.

Vaccinations

Because kidney injury can impair immune response, stay current on influenza, COVID‑19, pneumococcal, and hepatitis B vaccines per CDC guidelines.

Psychosocial support

Acute kidney issues can provoke anxiety about long‑term health. Consider counseling, support groups, or kidney‑patient advocacy organizations.

Prevention

While not all cases are preventable, many strategies reduce the likelihood of developing acute nephritis.

• Prudent drug use – take antibiotics or NSAIDs only when prescribed, complete the course, and avoid unnecessary over‑the‑counter pain relievers.
• Prompt treatment of infections – seek medical care for sore throats, skin infections, or urinary symptoms early.
• Vaccination – reduces risk of infections that can precipitate glomerulonephritis.
• Hydration – adequate fluid intake during illness, especially when using contrast studies or receiving certain antibiotics.
• Regular health checks – annual blood pressure, glucose, and kidney‑function screening for high‑risk individuals (diabetes, hypertension, autoimmune disease).
• Avoid nephrotoxins – limit exposure to heavy metals, illicit drugs, and high‑dose vitamin A or herbal supplements.

Complications

If left untreated or inadequately managed, acute nephritis can progress to serious outcomes:

• Acute kidney injury (AKI) requiring dialysis – occurs in 10‑30 % of severe cases<sup>[4]</sup>.
• Chronic kidney disease (CKD) – persistent loss of renal function in up to 15 % of patients after an episode of interstitial nephritis.
• Hypertension – due to sodium retention and activation of the renin‑angiotensin system.
• Electrolyte disturbances – severe hyperkalemia, metabolic acidosis, or hypocalcemia can be life‑threatening.
• Infection – especially if the patient needs temporary dialysis catheters.
• Progressive proteinuria – a risk factor for cardiovascular disease.

When to Seek Emergency Care

---

References:
[1] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Interstitial Nephritis.” 2023.
[2] WHO. “Acute Post‑streptococcal Glomerulonephritis – Global Burden.” 2022.
[3] KDIGO Clinical Practice Guideline for Acute Kidney Injury, 2021.
[4] Mayo Clinic. “Acute Kidney Injury (AKI).” Updated 2024.

```